| RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome L Duprez, N Takahashi, F Van Hauwermeiren, B Vandendriessche, ... Immunity 35 (6), 908-918, 2011 | 614 | 2011 |
| Verification, analytical validation, and clinical validation (V3): the foundation of determining fit-for-purpose for Biometric Monitoring Technologies (BioMeTs) JC Goldsack, A Coravos, JP Bakker, B Bent, AV Dowling, C Fitzer-Attas, ... npj digital Medicine 3 (1), 55, 2020 | 397 | 2020 |
| Therapies for rare diseases: therapeutic modalities, progress and challenges ahead E Tambuyzer, B Vandendriessche, CP Austin, PJ Brooks, K Larsson, ... Nature Reviews Drug Discovery 19 (2), 93-111, 2020 | 330 | 2020 |
| Extracellular ATP drives systemic inflammation, tissue damage and mortality A Cauwels, E Rogge, B Vandendriessche, S Shiva, P Brouckaert Cell death & disease 5 (3), e1102-e1102, 2014 | 291 | 2014 |
| Simultaneous targeting of IL-1 and IL-18 is required for protection against inflammatory and septic shock TV Berghe, D Demon, P Bogaert, B Vandendriessche, A Goethals, ... American journal of respiratory and critical care medicine 189 (3), 282-291, 2014 | 194 | 2014 |
| Citrulline supplementation improves organ perfusion and arginine availability under conditions with enhanced arginase activity KAP Wijnands, DM Meesters, KWY Van Barneveld, RGJ Visschers, ... Nutrients 7 (7), 5217-5238, 2015 | 58 | 2015 |
| Fit‐for‐purpose biometric monitoring technologies: leveraging the laboratory biomarker experience A Godfrey, B Vandendriessche, JP Bakker, C Fitzer‐Attas, N Gujar, ... Clinical and translational science 14 (1), 62-74, 2021 | 52 | 2021 |
| Computationally-efficient algorithm for real-time absence seizure detection in wearable electroencephalography J Dan, B Vandendriessche, WV Paesschen, D Weckhuysen, A Bertrand International Journal of Neural Systems 30 (11), 2050035, 2020 | 38 | 2020 |
| Severity of sepsis-induced acute kidney injury in a novel mouse model is age dependent B Maddens, B Vandendriessche, D Demon, R Vanholder, K Chiers, ... Critical care medicine 40 (9), 2638-2646, 2012 | 37 | 2012 |
| Verification, analytical validation and clinical validation (V3) of wearable dosimeters and light loggers M Spitschan, K Smolders, B Vandendriessche, B Bent, JP Bakker, ... Digital health 8, 20552076221144858, 2022 | 31 | 2022 |
| Of mice, men, and inflammation A Cauwels, B Vandendriessche, P Brouckaert Proceedings of the National Academy of Sciences 110 (34), E3150-E3150, 2013 | 31 | 2013 |
| A multiscale entropy-based tool for scoring severity of systemic inflammation B Vandendriessche, H Peperstraete, E Rogge, P Cauwels, E Hoste, ... Critical care medicine 42 (8), e560-e569, 2014 | 28 | 2014 |
| The soluble guanylate cyclase activator BAY 58-2667 protects against morbidity and mortality in endotoxic shock by recoupling organ systems B Vandendriessche, E Rogge, V Goossens, P Vandenabeele, JP Stasch, ... PLoS One 8 (8), e72155, 2013 | 27 | 2013 |
| EVIDENCE publication checklist for studies evaluating connected sensor technologies: explanation and elaboration C Manta, N Mahadevan, J Bakker, S Ozen Irmak, E Izmailova, S Park, ... Digital Biomarkers 5 (2), 127-147, 2021 | 25 | 2021 |
| Nitric oxide production by endotoxin preparations in TLR4-deficient mice A Cauwels, J Bultinck, R De Zwaef, B Vandendriessche, S Magez, ... Nitric Oxide 36, 36-43, 2014 | 24 | 2014 |
| Rigorous and rapid evidence assessment in digital health with the evidence DEFINED framework J Silberman, P Wicks, S Patel, S Sarlati, S Park, IO Korolev, JR Carl, ... NPJ Digital Medicine 6 (1), 101, 2023 | 17 | 2023 |
| Recommendations for defining and reporting adherence measured by biometric monitoring technologies: systematic review IM Olaye, MP Belovsky, L Bataille, R Cheng, A Ciger, KL Fortuna, ... Journal of Medical Internet Research 24 (4), e33537, 2022 | 15 | 2022 |
| Method for providing synchronization between a plurality of wireless body sensors and method for operating a synchronized network of wireless body sensors H Danneels, H De Clercq, H Safavi, B Vandendriessche US Patent App. 16/479,421, 2019 | 14 | 2019 |
| MAPK-activated protein kinase 2-deficiency causes hyperacute tumor necrosis factor-induced inflammatory shock B Vandendriessche, A Goethals, A Simats, E Van Hamme, P Brouckaert, ... BMC physiology 14, 1-10, 2014 | 13 | 2014 |
| TLR2 activation causes no morbidity or cardiovascular failure, despite excessive systemic nitric oxide production A Cauwels, B Vandendriessche, J Bultinck, B Descamps, E Rogge, ... Cardiovascular research 100 (1), 28-35, 2013 | 12 | 2013 |
Anje CauwelsVerified email at orionisbio.com
